Imaging Mass Spectrometry Revealed the Accumulation Characteristics of the 2-Nitroimidazole-Based Agent "Pimonidazole" in Hypoxia.
Hypoxia, or low oxygen concentration, is a key factor promoting tumor progression and angiogenesis and resistance of cancer to radiotherapy and chemotherapy. 2-Nitroimidazole-based agents have been widely used in pathological and nuclear medicine examinations to detect hypoxic regions in tumors; in...
Main Authors: | Yukiko Masaki, Yoichi Shimizu, Takeshi Yoshioka, Fei Feng, Songji Zhao, Kenichi Higashino, Yoshito Numata, Yuji Kuge |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5007049?pdf=render |
Similar Items
-
Imaging Mass Spectrometry Reveals Acyl-Chain- and Region-Specific Sphingolipid Metabolism in the Kidneys of Sphingomyelin Synthase 2-Deficient Mice.
by: Masayuki Sugimoto, et al.
Published: (2016-01-01) -
Fluorinated nitroimidazoles and their ruthenium complexes : potential hypoxia-imaging agents
by: Baird, Ian Robert
Published: (2009) -
Fluorinated nitroimidazoles and their ruthenium complexes : potential hypoxia-imaging agents
by: Baird, Ian Robert
Published: (2009) -
Increased [18F]FMISO accumulation under hypoxia by multidrug-resistant protein 1 inhibitors
by: Yoichi Shimizu, et al.
Published: (2021-01-01) -
Cellular mechanism of action of 2-nitroimidazoles as hypoxia-selective therapeutic agents
by: Diaz-Dussan, D., et al.
Published: (2022)